Dr. Jill Marie Meyer, MD

Dr. Meyer practices at Fresenius Kidney Care San Ysidro in San Diego, California.

Dr. Meyer's NPI, 1255394789, was assigned on April 7, 2006. Dr. Meyer graduated from American University of the Caribbean School of Medicine in 1996. Dr. Meyer's California license number on file is A95882.

Dr. Meyer's primary practice is Fresenius Kidney Care San Ysidro, at 3010 Del Sol Blvd, San Diego, CA 92154 in San Diego County. The practice phone is (619) 429-9690.

Dr. Meyer's primary practice is Fresenius Kidney Care San Ysidro in San Diego, California. Dr. Meyer is also affiliated with Sharp Chula Vista Medical Center. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Meyer to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meyer practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Meyer's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Meyer is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Meyer's licenses on file in 3 states: California, Minnesota and Georgia.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease and kidney disease among the conditions Dr. Meyer treats.

CMS data shows 2,238 Medicare services from Dr. Meyer across 13 procedure codes in 2024, for 430 Medicare patients. Medicare paid $192,304 for them.

CMS counts 430 Medicare patients who saw Dr. Meyer in 2024. The largest group is 75 to 84, with 151 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 64% are also on Medicaid. Their average risk score is 4.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Meyer's median patient age at 72, with 49% women.

In 2024, Dr. Meyer wrote 5,181 Medicare Part D claims for 417 patients. 67% of them were for generic drugs. CMS names the drug for 4,696 of them, across 68 drugs with 11 or more claims each, at $1,733,896 in total drug cost. In 2023, CMS named 4,345 claims across 71 drugs.

Dr. Meyer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Meyer as offering telehealth.

Dmand AI links 3 papers to Dr. Meyer in 2021. Dr. Meyer's most frequent co-authors are Dennis Eugene Amundson, DO, Robert Jan Kossmann, MD and Gilbert Seda, MD, PhD.

Dmand AI links Dr. Meyer to 2 clinical trials. Conditions studied include Kidney Diseases, Kidney Failure, Chronic and Renal Insufficiency, Chronic.

CMS Open Payments shows 480 general payments to Dr. Meyer from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Merck Sharp & Dohme Corporation paid the most, $1,221. It also lists 13 research payments totaling $13,831 from 2016 to 2022.

Dmand AI lists 1 award for Dr. Meyer, most recently CMS Stage 1 2012 in 2011.

Dr. Meyer graduated from American University of the Caribbean School of Medicine in 1996.

Dr. Meyer is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.